Track Your Dividends & Research Stocks: https://www.dividenddata.com/
2 extracted signals · 2 resolved · 0 still active
Dividend Data20 Jul 2025, 15:00 UTC
AI-generated source summary
The analyst discusses a dividend portfolio update and shares insights on two cheap dividend stocks the analyst is currently buying: MPLX, purchased at $50.45, offering a 7.59% yield, and HESM, at $37.82, also with a 7.51% yield. It is inferred that they are expected to go up, so a rough target can be estimated at 10% upside from its current price. The analyst expresses disappointment as HESM went up following the news and wants it to go back to 38 dollars. The analyst goes through earnings call of the company and says that the ten-year annual growth rate of the dividend is 8.84%, and the three-year CAGR is 10.7%. The most recent dividend increase for MPLX was 12.53%. The company is also a partnership, so its payouts are expected to grow mid single digits every year.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Dividend Data
Amazon Is Burning Cash. The Market Loved It.
Why I Invested $97,000 in Microsoft — MSFT Stock Analysis
Is Visa Stock a Buy in 2026?
Coca-Cola Isn't a Value Stock Anymore | KO Stock Analysis 2026
Software Stocks Just Flipped - Top 5 to Buy Now
SCHD Was Dead Money. It Just Beat the S&P 500.
Dividend Data
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.